Publications

Check our publications

Publications

Since 2007 GENVIP has published more than 430 publications

Showing 0 de
0 publications
highlight
Reset everything

Año

Reset

Journal

Reset
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
FEBRILE CHILDREN WITH COMORBIDITIES AT THE EMERGENCY DEPARTMENT - A MULTICENTRE OBSERVATIONAL STUDY
Borensztajn DM, Hagedoorn NN, Carrol ED, von Both U, Emonts M, van der Flier M, de Groot R, Herberg J, Kohlmaier B, Levin M, Lim E, Maconochie IK, Martinon-Torres F, Nijman RG, Pokorn M, Rivero-Calle I, Tsolia M, van der Velden FJS, Vermont C, Zavadska D, Zenz W, Zachariasse JM, Moll HA
Journal:
Eur J Pediatr
Publicación independiente
Impact factor
3.860
Q1
RSV PREVENTION IN ALL INFANTS: WHICH IS THE MOST PREFERABLE STRATEGY?
Esposito S, Abu Raya B, Baraldi E, Flanagan K, Martinon Torres F, Tsolia M, Zielen S
Journal:
Front Immunol
Publicación independiente
Impact factor
8.876
Q1
RISK ANALYSIS BY AGE ON THE BURDEN OF MENINGOCOCCAL DISEASE IN SPAIN
Rivero-Calle I, Raguindin PF, Pardo-Seco J, Martinon-Torres F
Journal:
Vaccines
Publicación independiente
Impact factor
4.961
Q2
MENINGOCOCCAL B VACCINE EFFECTIVENESS
Banzhoff A, Martinón-Torres F
Journal:
J Pediatr
Publicación independiente
Impact factor
6.314
Q1
GLOBAL, REGIONAL, AND NATIONAL DISEASE BURDEN ESTIMATES OF ACUTE LOWER RESPIRATORY INFECTIONS DUE TO RESPIRATORY SYNCYTIAL VIRUS IN CHILDREN YOUNGER THAN 5 YEARS IN 2019: A SYSTEMATIC ANALYSIS
Li Y, Wang X, Blau DM, Caballero MT, Feikin DR, Gill CJ, Madhi SA, Omer SB, Simões EAF, Campbell H, Pariente AB, Bardach D, Bassat Q, Casalegno JS, Chakhunashvili G, Crawford N, Danilenko D, Do LAH, Echavarria M, Gentile A, Gordon A, Heikkinen T, Huang QS, Jullien S, Krishnan A, Lopez EL, Markić J, Mira-Iglesias A, Moore HC, Moyes J, Mwananyanda L, Nokes DJ, Noordeen F, Obodai E, Palani N, Romero C, Salimi V, Satav A, Seo E, Shchomak Z, Singleton R, Stolyarov K, Stoszek SK, von Gottberg A, Wurzel D, Yoshida LM, Yung CF, Zar HJ; Respiratory Virus Global Epidemiology Network, Nair H; RESCEU investigators (Martinón-Torres F)
Journal:
Lancet
Publicación independiente
Impact factor
202.710
Q1
Year:
2022
Doi:
¿Dónde se esconde el virus respiratorio sincitial?
Martinón-Torres F, González-Barcala FJ
Journal:
Arch Bronconeumol
Publicación independiente
Impact factor
6.333
Q1
A TOOL FOR EARLY ESTIMATION OF INFLUENZA VACCINATION COVERAGE IN SPANISH GENERAL POPULATION AND HEALTHCARE WORKERS IN THE 2018-19 SEASON: THE GRIPÓMETRO
Díez-Domingo J, Redondo Margüello E, Ortiz de Lejarazu Leonardo R, Gil de Miguel Á, Guillén Ortega JM, Rincón Mora J, Martinón-Torres F
Journal:
BMC Public Health
Publicación independiente
Impact factor
4.135
Q2
WHOOPING COUGH: THE VISIBLE ENEMY
González-Barcala FJ, Villar-Álvarez F, Martinón-Torres F
Journal:
Arch Bronconeumol
Publicación independiente
Impact factor
6.333
Q1
ROLE AND DIAGNOSTIC PERFORMANCE OF HOST EPIGENOME IN RESPIRATORY MORBIDITY AFTER RSV INFECTION: THE EPIRESVI STUDY.
Pischedda S, Rivero-Calle I, Gómez-Carballa A, Cebey-López M, Barral-Arca R, Gómez-Rial J, Pardo-Seco J, Curras-Tuala MJ, Viz-Lasheras S, Bello X, Crujeiras AB, Diaz-Lagares A, González-López MT, Martinón-Torres F, Salas A; GENDRES consortium
Journal:
Front Immunol
Publicación independiente
Impact factor
8.786
Q1
EVALUATION OF BNT162B2 VACCINE EFFECTIVENESS IN GALICIA, NORTHWEST SPAIN
Pardo-Seco J, Mallah N, López-Pérez LR, González-Pérez JM, Rosón B, Otero-Barrós MT, Durán-Parrondo C, Rodríguez-Tenreiro C, Rivero-Calle I, Gómez-Carballa A, Salas A, Martinón-Torres F
Journal:
Int J Environ Res Public Health
Publicación independiente
Impact factor
3.390
Q2
¿Dónde se esconde el virus respiratorio sincitial?
Martinón-Torres F, González-Barcala FJ
Journal:
Arch Bronconeumol
Publicación independiente
Impact factor
4.872
Q2
YEAR-TO-YEAR VARIATION IN ATTACK RATES COULD RESULT IN UNDERPOWERED RESPIRATORY SYNCYTIAL VIRUS VACCINE EFFICACY TRIALS
Billard MN, Wildenbeest J, Bont LJ, Nair H, McCracken JP, Oude Rengerink K; RESCEU Investigators (Martinón-Torres F)
Journal:
J Clin Epidemiol
Publicación independiente
Impact factor
6.437
Q1
Year:
2022
Doi:
COST-EFFECTIVENESS OF RESPIRATORY SYNCYTIAL VIRUS DISEASE PREVENTION STRATEGIES: MATERNAL VACCINE VERSUS SEASONAL OR YEAR-ROUND MONOCLONAL ANTIBODY PROGRAM IN NORWEGIAN CHILDREN
Li X, Bilcke J, Vázquez Fernández L, Bont L, Willem L, Wisløff T, Jit M, Beutels P; REspiratory Syncytial virus Consortium in EUrope (RESCEU) Investigators. (martinón-Torres F)
Journal:
J Infect Dis
Publicación independiente
Impact factor
5.226
Q1
Year:
2022
Doi:
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE II TRIAL TO EXPLORE THE EFFECTS OF A GABAA-Α5 NAM (BASMISANIL) ON INTELLECTUAL DISABILITY ASSOCIATED WITH DOWN SYNDROME
Goeldner C, Kishnani PS, Skotko BG, Casero JL, Hipp JF, Derks M, Hernandez MC, Khwaja O, Lennon-Chrimes S, Noeldeke J, Pellicer S, Squassante L, Visootsak J, Wandel C, Fontoura P, d'Ardhuy XL; Clematis Study Group (Martinón-Torres F)
Journal:
J Neurodev Disord
Publicación independiente
Impact factor
4.025
Q2
Year:
2022
Doi:
PERFORMANCE ASSESSMENT OF A RAPID MOLECULAR RESPIRATORY SYNCYTIAL VIRUS POINT-OF-CARE TEST: A PROSPECTIVE COMMUNITY STUDY IN OLDER ADULTS
Zuurbier RP, Korsten K, Verheij TJM, Butler C, Adriaenssens N, Coenen S, Gruselle O, Vantomme V, van Houten MA, Bont LJ, Wildenbeest JG; REspiratory Syncytial Virus Consortium in EUrope (RESCEU) Investigators. (Martinón-Torres F)
Journal:
J Infect Dis
Publicación independiente
Impact factor
5.226
Q1
Year:
2022
Doi:
RAPID VIRAL TESTING AND ANTIBIOTIC PRESCRIPTION IN FEBRILE CHILDREN WITH RESPIRATORY SYMPTOMS VISITING EMERGENCY DEPARTMENTS IN EUROPE
Tan CD, Hagedoorn NN, Dewez JE, Borensztajn DM, von Both U, Carrol ED, Emonts M, van der Flier M, de Groot R, Herberg J, Kohlmaier B, Levin M, Lim E, Maconochie IK, Martinon-Torres F, Nijman RG, Pokorn M, Rivero-Calle I, Strle F, Tsolia M, Vermont CL, Yeung S, Zachariasse JM, Zenz W, Zavadska D, Moll HA; PERFORM Consortium
Journal:
Pediatr Infect Dis J
Publicación independiente
Impact factor
2.129
Q4
Pediatric vaccination against COVID-19 and despite COVID-19
Martinón-Torres F
Journal:
An Pediatr (Engl Ed)
Publicación independiente
Impact factor
1.500
Q4
A SYSTEMATIC REVIEW OF EUROPEAN CLINICAL PRACTICE GUIDELINES FOR RESPIRATORY SYNCYTIAL VIRUS PROPHYLAXIS
Reeves RM, van Wijhe M, Lehtonen T, Stona L, Teirlinck AC, Vazquez Fernandez L, Li Y, Osei-Yeboah R, Fischer TK, Heikkinen T, van Boven M, Bøås H, Donà D, Barbieri E, Campbell H; RESCEU Investigators. (Martinón-Torres F)
Journal:
J Infect Dis
Publicación independiente
Impact factor
5.022
Q1
Year:
2022
Doi:
EQUITY IN VACCINATION POLICIES TO OVERCOME SOCIAL DEPRIVATION AS A RISK FACTOR FOR INVASIVE MENINGOCOCCAL DISEASE.
Taha MK, Martinon-Torres F, Köllges R, Bonanni P, Safadi MAP, Booy R, Smith V, Garcia S, Bekkat-Berkani R, Abitbol V
Journal:
Expert Rev Vaccines
Publicación independiente
Impact factor
5.217
Q2
COVIDPHY: A TOOL FOR PHYLOGEOGRAPHIC ANALYSIS OF SARS-COV-2 VARIATION
Bello X, Pardo-Seco J, Gómez-Carballa A, Weissensteiner H, Martinón-Torres F, Salas A
Journal:
Environ Res
Publicación independiente
Impact factor
6.498
Q1
CHARACTERISTICS AND MANAGEMENT OF ADOLESCENTS ATTENDING THE ED WITH FEVER: A PROSPECTIVE MULTICENTRE STUDY
Borensztajn D, Hagedoorn NN, Carrol E, von Both U, Dewez JE, Emonts M, van der Flier M, de Groot R, Herberg J, Kohlmaier B, Levin M, Lim E, Maconochie I, Martinon Torres F, Nijman R, Pokorn M, Rivero-Calle I, Tsolia M, Vermont C, Zavadska D, Zenz W, Zachariasse J, Moll HA; PERFORM Consortium: Personalised Risk assessment in febrile children to optimise Real-life Management across the European Union.
Journal:
BMJ Open
Publicación independiente
Impact factor
2.692
Q2
EVOLVING STRATEGIES FOR MENINGOCOCCAL VACCINATION IN EUROPE: OVERVIEW AND KEY DETERMINANTS FOR CURRENT AND FUTURE CONSIDERATIONS
Martinón-Torres F, Taha MK, Knuf M, Abbing-Karahagopian V, Pellegrini M, Bekkat-Berkani R, Abitbol V
Journal:
Pathog Glob Health
Publicación independiente
Impact factor
2.894
Q2
IMPROVING EMPIRIC ANTIBIOTIC PRESCRIBING IN PEDIATRIC BLOODSTREAM INFECTIONS: A POTENTIAL APPLICATION OF WEIGHTED-INCIDENCE SYNDROMIC COMBINATION ANTIBIOGRAMS (WISCA)
Cook A, Sharland M, Yau Y; PediBSI Group*, Bielicki J. (Martinón-Torres F)
Journal:
Expert Rev Anti Infect Ther.
Publicación independiente
Impact factor
5.091
Q1
Year:
2022
Doi:
No results found.
Reduced schedules of 4CMenB vaccine in infants and catch-up series in children: Immunogenicity and safety results from a randomised open-label phase 3b trial
Martinón-Torres F, Safadi MAP, Martinez AC, Marquez PI, Torres JCT, Weckx LY, Moreira ED Junior, Mensi I, Calabresi M, Toneatto D
Doi:
Vaccine
Factor de impacto:
Q2
Doi:
Phylogenetic and population-based approaches to mitogenome variation do not support association with male infertility.
Gómez-Carballa A, Pardo-Seco J, Martinón-Torres F, Salas A
Doi:
J Hum Gene
Factor de impacto:
Q2
Doi:
Meningococcal serogroup B-specific responses after vaccination with bivalent rLP2086: 4 year follow-up of a randomised, single-blind, placebo-controlled, phase 2 trial
Marshall HS, Richmond PC, Beeslaar J, Jiang Q, Jansen KU, Garcés-Sánchez M, Martinón-Torres F, Szenborn L, Wysocki J, Eiden J, Harris SL, Jones TR, Lee SS, Perez JL; 6108A12001 Study Investigators.
Doi:
Lancet Infect Dis
Factor de impacto:
Q1
Doi:
Circulating Antibody 1 and 2 Years After Vaccination With the 13-Valent Pneumococcal Conjugate Vaccine in Preterm Compared With Term Infants
F. Martinón-Torres, J. Wysocki, K. J. Center, H. Czajka, E. Majda-Stanislawska, F. Omeñaca, A. Concheiro-Guisan, F. Gimenez-Sanchez, L. Szenborn, D. Blázquez-Gamero, L. Moreno-Galarraga, P. C. Giardina, G. Sun, W. C. Gruber, D. A. Scott and A. Gurtman
Doi:
Pediatr Infect Dis J
Factor de impacto:
Q2
Doi:
ISL1 is a major susceptibility gene for classic bladder exstrophy and a regulator of urinary tract development
Zhang R, Knapp M, Suzuki K, Kajioka D, Schmidt JM, Winkler J, Yilmaz O, Pleschka M, Cao J, Clementson Kockum C, Barker G, Holmdahl G, Beaman G, Keene D, Woolf AS, Cervellione RM, Wei Cheng, Wilkins S, Gearhart JP, Sirchia F, Di Grazia M, Ebert AK, Rösch W, Ellinger J, Jenetzky E, Zwink N, Feitz WF, Marcelis C, Schumacher J, Martinón-Torres F, Lloyd Hibberd M,Chuen Khor C, Heilmann-Heimbach S, Barth S, Boyadjiev SA, Brusco A, Ludwig M, Newman W, Nordenskjöld A, YamadaG, Odermatt B, Reutter H
Doi:
Scientific Reports
Factor de impacto:
Q1
Doi:
Otra lección británica sobre vacunas frente al meningococo
Federico Martinón Torres
Doi:
Evid. Pediatr
Factor de impacto:
Doi:
Immunogenicity and safety of concomitant administration of meningococcal serogroup B (4CMenB) and serogroup C (MenC-CRM) vaccines in infants: A phase 3b, randomized controlled trial
Marco Aurelio P. Safadi, Federico Martinon-Torres, Lily Yin Weckx, Edson Duarte Moreira Junior, Eduardo Jorge da Fonseca Lima, Ilhem Mensi, Marco Calabresi, Daniela Toneatto
Doi:
Vaccine
Factor de impacto:
Q2
Doi:
International Survey of Critically Ill Children With Acute Neurologic Insults: The Prevalence of Acute Critical Neurological Disease in Children: A Global Epidemiological Assessment Study
Ericka L. Fink, Patrick M. Kochanek, Robert C. Tasker, John Beca, Michael J. Bell, Robert S. B. Clark, Jamie Hutchison, Monica S. Vavilala, Anthony Fabio, Derek C. Angus, R. Scott Watson, on behalf of the Prevalence of Acute critical Neurological Disease in Children: A Global Epidemiological Assessment (PANGEA) Investigators, Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network, and Pediatric Neurocritical Care Research Group (PNCRG) (Smith C, Ryan C, Koch J, Walson K, Truemper E, Flori H, Simon J, Exo J, Markovitz B, Morzov R, LaRovere K, Nishisaki A, Prodell J, Sisko M, McGowan S, Idell T, Twelves C, Kamens W, Park B, Diliberto MA, Fink E, Abraham A, Hanson S, Murkowski K, Nowak J, Zielinski E, Overman A, Tieves K, Williams T, Hughes-Schalk A, Dean N, Bala A, Watson A, Wheeler D, Banschbach S, Beckman E, Frank E, Nett S, Jarvis JD, Higgerson R, Christie L, Reed J, Cheifetz I, Tate S, Uhl T, Haskins-Kiefer C, Hendricks P, Green J, Barron-Nelson R, Baisch S, Evenson J, Wendorf H, McKinley D, Sankey J, Bembea M, Noje C, White E, O'Brien N, Maa T, Zink M, Weidner B, Biagas K, Superville M, Traube C, Carlo C, Thomas N, Spear D, Buttram S, Franken A, Bennett T, Kim EH, Nitu M, Rider C, Vavilala MS, Lum D, Parker M, Culver K, Loftis L, Jaimon N, Shellington D, Foley J, Irazuzta J, Alleyne T, Bateman S, Sylvia M, Cholette JM, Willson D, Kelly R, Pineda J, Hicks T, Middleton D, Day T, Li S, Kandil S, Giuliano J, Skippen P, Wensley D, Krahn G, Bourdages M, Dugas MA, Gosselin L, Santschi M, Fraser D, Blom C, Jouvet P, Poitras N, Bertout L, Dumitrascu M, Gottesman R, Trudel K, Hutchison J, Kandath S, Van Huyse J, Fusco K, Niera P, Iolster T, Barbosa M, Soares V, Lima F, Betanzo RB, Fernández Laverde M, Becerra R, Guilbert J, Léger PL, Ringuier B, Brissaud O, Payen V, Milesi C, Liet JM, Legrande A, Breining A, Bienz J, Javouhey E, Ginhoux T, Courtil-Teyssedre S, Bergounioux J, Sachs P, Leclerc F, Lampin ME, Amigoni A, Marzollo A, Barzdina A, Tibboel D, Geleijns K, van Gestel S, Dinis A, García-Iñiguez J, Madurga-Revilla P, Martinon-Torres F, De Castro MJ, Lopez-Herce J, Urbano J, García-Soler P, Fernandez-Carrion F, Rossich R, Arjona D, Borrego R, Karam O, Dursun O, Tekguc H, Kendirli T, Odek C, Yaman A, Arslankoylu A, Tume L, Scholefield B, Winmill H, Morley S, White D, Mukhtyar B, Agbeko R, Peters M, Jones A, Inwald D, Brewer A, Abdulla A, Deep A, Nsirim E, Shefler A, Joshi R, Muhuntha G, Hudnott P, MacDonald M, Pappachan J, Gray MP, Rushforth K, Abdelmogheth AA, Mohamed AF, Dhande NR, Abdulrahim RA, Saleh S, Al-Hasani S, Argent A, Salie S, Ranjit S, Jayakumar I, Kamath S, P AV, Cheung HM, Wang Y, Festa M, Walker K, Watts N, Erickson S, Slater A, Long D, Butt W, Delzoppo C, Yung M, Ganu S, Letton G, Sherring C, Rea M, Bushell T)
Doi:
Pediatric Critical Care Med
Factor de impacto:
Q1
Doi:
Salivary epidermal growth factor correlates with hospitalization length in rotavirus infection
J. Gómez-Rial, M. J. Curras-Tuala, C. Talavero-González, C. Rodríguez-Tenreiro, L. Vilanova-Trillo, A. Gómez-Carballa, I. Rivero-Calle, A. Justicia-Grande, J. Pardo-Seco, L. Redondo-Collazo, A. Salas and F. Martinón-Torres
Doi:
BMC Infec Dis
Factor de impacto:
Q3
Doi:
Safety, Tolerability and Immunogenicity of Pentavalent Rotavirus Vaccine Manufactured by a Modified Process
Federico Martinón-Torres, David Greenberg, Meera Varman, John A. Killar, Darcy Hille, Erica L. Strable, Jon E. Stek, and Susan S. Kaplan,
Doi:
Pediatr Infect Dis J.
Factor de impacto:
Q2
Doi:
A META-ANALYSIS OF MULTIPLE WHOLE BLOOD GENE EXPRESSION DATA UNVEILS A DIAGNOSTIC HOST-RESPONSE TRANSCRIPT SIGNATURE FOR RESPIRATORY SYNCYTIAL VIRUS
Ruth Barral-Arca, Alberto Gómez-Carballa, Miriam Cebey-López, Xabier Bello, Federico Martinón-Torres, and Antonio Salas
Int. J. Mol. Sci.
Factor de impacto:
Q1
Doi:
RESPIRATORY SYNCYTIAL VIRUS-ASSOCIATED ACUTE LOWER RESPIRATORY INFECTIONS IN CHILDREN WITH BRONCHOPULMONARY DYSPLASIA: SYSTEMATIC REVIEW AND META-ANALYSIS.
Chaw PS, Hua L, Cunningham S, Campbell H, Mikolajczyk R, Nair H; RESCEU Investigators (Nair H, Campbell H, Shi T, Zhang S, Li Y, Hua L, Openshaw P, Wedzicha J, Falsey A, Miller M, Bont L, Pollard A, Molero E, Martinon-Torres F, Heikkinen T, Meijer A, Fischer TK, van den Berge M, Giaquinto C, Mikolajczyk R, Chaw PS, Gallichan S, Kieffer A, Demont C, Hackett J, Cai B, Knirsch C, Leach A, Stoszek S, Cheret A, Gavart S, Aerssens J, Fuentes R, Rosen B)
J Infect Dis.
Factor de impacto:
Q1
Doi:
PHARMACOKINETICS, SAFETY AND ANTIVIRAL EFFECTS OF MULTIPLE DOSES OF THE RESPIRATORY SYNCYTIAL VIRUS FUSION PROTEIN INHIBITOR, JNJ-53718678, IN INFANTS HOSPITALIZED WITH RSV INFECTION: A RANDOMIZED PHASE 1B STUDY
Federico Martinón-Torres, Sarah Rusch, Dymphy Huntjens, Bart Remmerie, Johan Vingerhoets, Katie McFadyen, Fernando Ferrero, Eugenio Baraldi, Pablo Rojo, Cristina Epalza, Marita Stevens
Clin Infect Dis
Factor de impacto:
Q1
Doi:
DIAGNOSTIC CRITERIA FOR ACUTE FPIES: WHAT ARE WE MISSING?
Marta Vazquez-Ortiz, Laura Argiz, Adrianna Machinena, Luis Echeverria, Cristina Blasco, Ana Prieto, Sonsoles Infante, Leticia Vila, Emilio Garcia, Purificación Gonzalez-Delgado, SoniaVazquez-Cortes, Simona Barni, Frederico Martinon-Torres, BIO-FPIES study network
J Allergy Clin Immunol Pract
Factor de impacto:
Q1
Doi:
EVALUATION OF THE IMPACT OF THE SPANISH CONSENSUS DOCUMENT ON THE APPROACH TO OSTEOARTICULAR INFECTIONS IN SPAIN THROUGH THE PAEDIATRICS OSTEOARTICULAR INFECTIONS NETWORK (RIOPED).
Nunez Cuadros, Esmeralda; Calvo Rey, Cristina; Saavedra-Lozano, Jesus and Red RIOPED (Federico Martinón and Irene Rivero)
An Ped
Factor de impacto:
Q4
Doi:
IMMUNOGENICITY, TRANSPLACENTAL TRANSFER OF PERTUSSIS ANTIBODIES AND SAFETY FOLLOWING PERTUSSIS IMMUNIZATION DURING PREGNANCY:EVIDENCE FROM A RANDOMIZED, PLACEBO-CONTROLLED TRIAL
Kirsten P. Perrett, Scott A. Halperin, Terry Nolan, Cristina Martínez Pancorbo, Bruce Tapiero, Federico Martinón-Torres, Zbynek Stranak, Miia Virta, Otto G. Vanderkooi, Pavel Kosina, Maria Begoña Encinas Pardilla, Ignacio Cristobal García, Gian Vincenzo Zuccotti, Lusine Kostanyanm, Nadia Meyer, Maria Angeles Ceregido, Brigitte Cheuvart, Sherine O. Kuriyakose, Manuel Marcos Fernández, Miguel Ángel Rodríguez Zambrano, Adrián Martín García, Juan Eloy Asenjo de la Fuente, Maria Dolores Camacho Marín, María de la Calle Fernández-Miranda, Yolanda Romero Espinar, Paola Giovanna Marchisio, Paolo Manzoni, Narcisa Mesaros
Vaccine
Factor de impacto:
Q3
Doi:
IMPACT OF TETANUS-DIPHTHERIA-ACELLULAR PERTUSSIS IMMUNIZATION DURING PREGNANCY ON SUBSEQUENT INFANT IMMUNIZATION SERORESPONSES: FOLLOW-UP FROM A LARGE RANDOMIZED PLACEBO-CONTROLLED TRIAL
1Kirsten P. Perrett, Scott A. Halperin, Terry Nolan, Alfonso Carmona Martínez, Federico Martinón-Torres, Jose García-Sicilia, Miia Virta , Otto G. Vanderkooi, Gian Vincenzo Zuccotti, Paolo Manzoni, Lusine Kostanyan, Nadia Meyer, Maria Angeles Ceregido, Brigitte Cheuvart , Sherine O. Kuriyakose l, Zbynek Stranak, Jose M. Merino Arribas, María José Cilleruelo Ortega, Mariano Miranda-Valdivieso, Begoña Arias Novas, Jose Tomas Ramos Amador, Felix Omeñaca, Manuel Baca, Paola Giovanna Marchisio, Narcisa Mesaros
Vaccine
Factor de impacto:
Q3
Doi:
SURVEY BY TEDDY EUROPEAN NETWORK OF EXCELLENCE FOR PAEDIATRIC CLINICAL RESEARCH DEMONSTRATES POTENTIAL FOR EUROPE-WIDE TRIALS
Ruggieri L, Bonifazi D, Landi A, Bonifazi F, Bartoloni F, Costello M, Felisi MG, Gasthuys E, Godo A, Martinon Torres F, Nadal D, Nuytinck L, Rocchi F, Turner M, Ceci A
Acta paed
Factor de impacto:
Q2
Doi:
REACTIONS ON RE-EXPOSURE FOLLOWING NEGATIVE AND INCONCLUSIVE FOLLOW-UP FOOD CHALLENGES IN CHILDREN WITH ACUTE FPIES
Laura Argiz, Sonsoles Infante, Adrianna Machinena, Mariona Pascal, Luis Echeverria, Simona Barni, Teresa Garriga-Baraut, Stefania Arasi, Jose Domingo Moure, Alberto Gomez-Carballa, Federico Martinon-Torres, Robert J Boyle, Marta Vazquez-Ortiz, BIO-FPIES study network
J Allergy Clin Immunol Pract
Factor de impacto:
Q1
Doi:
ENFERMEDAD MENINGOCÓCICA: ¿PODEMOS PREDECIR LO IMPREDECIBLE?
Federico Martinón-Torresy Antoni Trillac
Med Clin
Factor de impacto:
Q3
Doi: